Is adjuvant chemotherapy beneficial for surgical stage I ovarian clear cell carcinoma?-Reference-Cited by-同舟云学术

Is adjuvant chemotherapy beneficial for surgical stage I ovarian clear cell carcinoma?

Published:2017-10 Issue:1 Volume:147 Page:54-60
ISSN:0090-8258
Container-title:Gynecologic Oncology
language:en
Short-container-title:Gynecologic Oncology

Author:

Hogen Liat,Brar Harry,Covens Allan,Bassiouny Dina,Bernardini Marcus Q.,Gien Lilian T.,Ferguson Sarah E.,Vicus Danielle

Publisher

Elsevier BV

Subject

Obstetrics and Gynaecology,Oncology

Reference36 articles.

1. Clear cell carcinoma of the ovary: a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy in stage III disease;Goff;Gynecol. Oncol.,1996

2. Do clear cell ovarian carcinomas have poorer prognosis compared to other epithelial cell types? A study of 1411 clear cell ovarian cancers;Chan;Gynecol. Oncol.,2008

3. Prognostic relevance of uncommon ovarian histology in women with stage III/IV epithelial ovarian cancer;MacKay;Int. J. Gynecol. Cancer,2010

4. Clinical characteristics of clear cell carcinoma of the ovary - a distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy;Kigawa;Cancer,2000

5. Mechanisms of chemoresistance and poor prognosis in ovarian clear cell carcinoma;Itamochi;Cancer Sci.,2008

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adjuvant Chemotherapy for Stage I Ovarian Clear Cell Carcinoma;O&G Open;2024-09

2. Prognostic factors and impact of fertility-sparing surgery in women with FIGO stage I clear cell ovarian carcinoma: a Surveillance, Epidemiology, and End Results (SEER) analysis;2023-07-13

3. Clear Cell Carcinoma of the Ovary;Essentials of Diagnostic Gynecological Pathology;2023

4. Patients with stage IA ovarian clear cell carcinoma do not require chemotherapy following surgery;Cancer Medicine;2022-11-23

5. Impact of Adjuvant Chemotherapy on FIGO Stage I Ovarian Clear Cell Carcinoma: A Systematic Review and Meta-Analysis;Frontiers in Oncology;2022-05-17